TY - JOUR
T1 - Update on noninvasive imaging of right ventricle dysfunction in pulmonary hypertension
AU - Truong, Uyen
AU - Meinel, Katharina
AU - Haddad, Francois
AU - Koestenberger, Martin
AU - Carlsen, Jørn
AU - Ivy, Dunbar
AU - Jone, Pei Ni
N1 - Funding Information:
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure forms (available at http://dx.doi. org/10.21037/cdt-20-272). The series “Right Ventricular Dysfunction” was commissioned by the editorial office without any funding or sponsorship. MK served as the unpaid Guest Editor of the series. UT reports grants from NIH NHLBI, from null, outside the submitted work. JC reports grants and other from Actelion, grants from Astra Zeneca, grants from United Therapeutics, outside the submitted work. DI reports grants and non-financial support from Actelion, grants from Bayer, grants from Glaxo Smith Kline, grants from Liquidia, grants and nonfinancial support from United Therapeutics, grants from Lilly, outside the submitted work. The other authors have
Publisher Copyright:
© Cardiovascular Diagnosis and Therapy. All rights reserved.
PY - 2020/10
Y1 - 2020/10
N2 - Pulmonary hypertension (PH) is a progressive disease affecting patients across the life span. The pathophysiology primarily involves the pulmonary vasculature and right ventricle (RV), but eventually affects the left ventricular (LV) function as well. Safe, accurate imaging modalities are critical for diagnosis, serial monitoring, and tailored therapy. While cardiac catheterization remains the conventional modality for establishing diagnosis and serial monitoring, noninvasive imaging has gained considerable momentum in providing accurate assessment of the entire RV-pulmonary axis. In this state-of-the-art review, we will discuss the most recent developments in echocardiography, magnetic resonance imaging, and computed tomography in PH evaluation from pediatric to adult population.
AB - Pulmonary hypertension (PH) is a progressive disease affecting patients across the life span. The pathophysiology primarily involves the pulmonary vasculature and right ventricle (RV), but eventually affects the left ventricular (LV) function as well. Safe, accurate imaging modalities are critical for diagnosis, serial monitoring, and tailored therapy. While cardiac catheterization remains the conventional modality for establishing diagnosis and serial monitoring, noninvasive imaging has gained considerable momentum in providing accurate assessment of the entire RV-pulmonary axis. In this state-of-the-art review, we will discuss the most recent developments in echocardiography, magnetic resonance imaging, and computed tomography in PH evaluation from pediatric to adult population.
KW - Cardiac magnetic resonance imaging
KW - Cardiac tomography imaging
KW - Echocardiography
KW - Pulmonary hypertension (PH)
UR - http://www.scopus.com/inward/record.url?scp=85094809052&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094809052&partnerID=8YFLogxK
U2 - 10.21037/cdt-20-272
DO - 10.21037/cdt-20-272
M3 - Review article
C2 - 33224776
AN - SCOPUS:85094809052
VL - 10
SP - 1604
EP - 1624
JO - Cardiovascular Diagnosis and Therapy
JF - Cardiovascular Diagnosis and Therapy
SN - 2223-3652
IS - 5
ER -